Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pegvisomant or pasirotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.
Endocr Relat Cancer. 2024 May 1:ERC-24-0043. doi: 10.1530/ERC-24-0043. Online ahead of print.
Endocr Relat Cancer. 2024.
PMID: 38713182
Differences between GH and PRL co-secreting and GH-secreting pituitary adenomas. A series of 604 cases.
Araujo-Castro M, Biagetti B, Menéndez Torre E, Novoa-Testa I, Cordido F, Pascual Corrales E, Rodríguez Berrocal V, Guerrero-Pérez F, Vicente A, Percovich JC, García Centeno R, González L, Ollero García MD, Irigaray Echarri A, Moure Rodríguez MD, Novo-Rodríguez C, Calatayud M, Villar R, Bernabéu I, Alvarez-Escola C, Benítez Valderrama P, Tenorio-Jimenéz C, Abellán Galiana P, Venegas Moreno E, González Molero I, Iglesias P, Blanco C, Vidal-Ostos De Lara F, de Miguel P, López Mezquita E, Hanzu F, Aldecoa I, Lamas C, Aznar S, Aulinas A, Calabrese A, Gracia P, Recio-Córdova JM, Aviles M, Asensio-Wandosel D, Sampedro M, Ruz-Caracuel I, Camara R, Paja M, Fajardo-Montañana C, Marazuela M, Puig-Domingo M.
Araujo-Castro M, et al. Among authors: lopez mezquita e.
J Clin Endocrinol Metab. 2024 Mar 4:dgae126. doi: 10.1210/clinem/dgae126. Online ahead of print.
J Clin Endocrinol Metab. 2024.
PMID: 38436926
Item in Clipboard
Effectiveness and safety of the radiofrequency ablation of single hyperfunctioning parathyroid lesions suggestive of adenomas in primary hyperparathyroidism.
León Utrero S, Garrido-Pareja F, López-Ibarra P, Quesada-Charneco M, López-Mezquita E, Ávila-Rubio V, Martín-Rodríguez JL.
León Utrero S, et al. Among authors: lopez mezquita e.
J Endocrinol Invest. 2023 Nov;46(11):2269-2273. doi: 10.1007/s40618-023-02078-4. Epub 2023 Apr 9.
J Endocrinol Invest. 2023.
PMID: 37032399
Item in Clipboard
New Metrics to Assess Type 2 Diabetes After Bariatric Surgery: The "Time-Within-Remission Range".
Hollanda A, Lecube A, Rubio MA, Sánchez E, Vilarrasa N, Oliva JG, Fernández-Soto ML, Salas-Salvadó J, Ballesteros-Pomar MD, Ciudin A, Torres F, Vidal C, Morales MJ, Valdés S, Pellitero S, Miñambres I, Masmiquel L, Goday A, Suarez L, Flores L, Bueno M, Caixàs A, Bretón I, Cámara R, Olbeyra R, Penso R, José de la Cruz M, Simó-Servat A, Pereyra-García FM, López-Mezquita ET, Gils A, Fidilio E, Bandrés O, Martínez Á, Abuín J, Marques-Pamies M, Tuneu L, Arteaga M, Castañer O, Goñi F, Arrizabalaga C, Botana MA, Calañas A, Rebollo Á.
Hollanda A, et al. Among authors: lopez mezquita et.
J Clin Med. 2020 Apr 9;9(4):1070. doi: 10.3390/jcm9041070.
J Clin Med. 2020.
PMID: 32283783
Free PMC article.
Item in Clipboard
Cite
Cite